These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Total and capillary fingertip blood flow in Raynaud's phenomenon. Coffman JD; Cohen AS N Engl J Med; 1971 Jul; 285(5):259-63. PubMed ID: 5090397 [No Abstract] [Full Text] [Related]
3. Raynaud's disease and cooling of the fingers. Miller IA; Walder DN Br J Surg; 1972 Apr; 59(4):312. PubMed ID: 5020774 [No Abstract] [Full Text] [Related]
4. [Reserpine administration by retrograde intravenous route in patients with Raynaud's phenomenon]. Acevedo A; Arinoviche R; Palma A; Olea E; Guzmán G; Arriagada M; Grisanti M; Testar R Rev Med Chil; 1982 Nov; 110(11):1063-5. PubMed ID: 7184095 [No Abstract] [Full Text] [Related]
5. Effect of intra-arterial reserpine in patients suffering from Raynaud's phenomenon. Acevedo A; Reginato AJ; Schnell AM J Cardiovasc Surg (Torino); 1978; 19(1):77-84. PubMed ID: 627597 [TBL] [Abstract][Full Text] [Related]
6. Laser-Doppler measurement of digital blood flow regulation in normals and in patients with Raynaud's phenomenon. Kristensen JK; Engelhart M; Nielsen T Acta Derm Venereol; 1983; 63(1):43-7. PubMed ID: 6191488 [TBL] [Abstract][Full Text] [Related]
7. Suppression of Raynaud's phenomenon by methyldopa. Varadi DP; Lawrence AM Arch Intern Med; 1969 Jul; 124(1):13-8. PubMed ID: 5791479 [No Abstract] [Full Text] [Related]
8. Pharmacologic management of Raynaud's phenomenon. Day TW; Mendoza F South Med J; 1984 Sep; 77(9):1160-4. PubMed ID: 6385288 [TBL] [Abstract][Full Text] [Related]
12. [Pathophysiology and medical treatment of Raynaud's phenomena]. Adar R Harefuah; 1973 Feb; 84(4):227-8. PubMed ID: 4574182 [No Abstract] [Full Text] [Related]
13. [Rheographic evaluation of the changes in blood flow after superficial electric stimulation in patients with Raynaud's disease or syndrome]. Kruk M; Borkowski M; Wojtal E; Górewicz R Pol Tyg Lek; 1989 Oct 23-Nov 6; 44(43-45):921-3. PubMed ID: 2487760 [TBL] [Abstract][Full Text] [Related]
14. Methods of evaluating Raynaud's phenomenon for the purpose of pharmacotherapeutic research. Wouda AA Vasa Suppl; 1987; 18():32-9. PubMed ID: 3474798 [No Abstract] [Full Text] [Related]
15. Acute effect of topical minoxidil on digital blood flow in patients with Raynaud's phenomenon. Whitmore SE; Wigley FM; Wise RA J Rheumatol; 1995 Jan; 22(1):50-4. PubMed ID: 7699682 [TBL] [Abstract][Full Text] [Related]
16. Intra-arterial reserpine for Raynaud's syndrome. Systemic reactions without therapeutic benefit. Surwit RS; Gilgor RS; Duvic M; Allen LM; Neal JA Arch Dermatol; 1983 Sep; 119(9):733-5. PubMed ID: 6614959 [TBL] [Abstract][Full Text] [Related]
17. [Value and limitations of venous blocks using reserpine in acrosyndromes of the upper extremities]. Serise JM; Gironnet I; Dugrais G; Janvier G; Winnock S; Boissiéras P J Mal Vasc; 1984; 9(2):107-9. PubMed ID: 6747471 [TBL] [Abstract][Full Text] [Related]
18. The diagnosis and treatment of Raynaud's phenomenon. Porter JM; Snider RL; Bardana EJ; Rösch J; Eidemiller LR Surgery; 1975 Jan; 77(1):11-23. PubMed ID: 1078555 [TBL] [Abstract][Full Text] [Related]
20. Raynaud's phenomenon. Photoelectric plethysmography of the fingers of persons with and without Raynaud's phenomenon during cooling and warming up. Wouda AA Acta Med Scand; 1977; 201(6):519-23. PubMed ID: 878907 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]